About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming the treatment landscape for central nervous system (CNS) disorders. We are committed to delivering impactful scientific advancements by addressing critical healthcare gaps and developing innovative therapies. Our distinguished neuroscience portfolio features FDA-approved solutions for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, and migraine, along with multiple late-stage development initiatives targeting serious neurological and psychiatric illnesses affecting over 150 million individuals in the United States. Together, we aim to tackle significant challenges in brain health, empowering patients and their families to thrive.

